Old Web
English
Sign In
Acemap
>
authorDetail
>
D. Ingolia
D. Ingolia
Medicine
Idiotype
Immunotherapy
Immunology
Rituximab
3
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity
2019
Journal of Patient-Reported Outcomes
Lauren Nelson
Dana DiBenedetti
David M. Pariser
Dee Anna Glaser
Adelaide A. Hebert
H. Hofland
Janice Drew
D. Ingolia
K. K. Gillard
Sheri Fehnel
Show All
Source
Cite
Save
Citations (9)
Preliminary immune response (IR) results of a phase 2 study with idiotype (Id) immunotherapy after treatment with CVP and rituximab for follicular non-Hodgkin's lymphoma (FL)
2006
Journal of Clinical Oncology
John P. Leonard
K Mason
Thomas Theriault
K. Milner
T. Sornasse
D. Ingolia
Martha Mayo
Dan W. Denney
Show All
Source
Cite
Save
Citations (5)
An initial analysis of an allele-specific quantitative PCR (Q-PCR) assay which detects minimal residual disease (MRD) in the peripheral blood of follicular lymphoma (FL) patients
2006
Journal of Clinical Oncology
Thomas Theriault
N. Kautz
K Mason
D. Ingolia
Dan W. Denney
Show All
Source
Cite
Save
Citations (0)
1